JD Bagert

JD Bagert is an experienced and innovative leader currently serving as a Director at AstraZeneca, where they focus on biologics engineering and drug development, particularly in multispecific antibodies. JD has a proven track record of advancing complex biologics from concept to clinic and has held roles including Associate Director, Senior Scientist, and Associate Principal Scientist at the same company. Prior to this, JD was an Associate Research Scholar at Princeton University, specializing in the study of epigenetic regulatory mechanisms in cells. JD earned a PhD in Bioengineering from the California Institute of Technology and a BS in Chemical and Biomolecular Engineering from The Johns Hopkins University.